ClinicalTrials.Veeva

Menu

Brain-Gut-Microbiota Interaction in IBS

H

Haukeland University Hospital

Status

Unknown

Conditions

Irritable Bowel Syndrome
Functional Gastrointestinal Disorders

Treatments

Other: Dietary lowFODMAP intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT04296552
2015-01621

Details and patient eligibility

About

Are you what you eat? How can dietary components influence microbial composition of the gut and function of the peripheral and central nervous system? The gut and brain is linked through complex mechanisms of sensorimotor functions of the immune system, the hypothalamic-pituitary-adrenal-axis, the enteric nervous system and microbiota.

In this project, a multitude of factors contributing to the bidirectional neurobiological communication along the brain-but-axis will be investigated. No disease of the brain-gut axis has been elucidated, therefore our investigations involves approaching a large span of components and processes involved in the axis. This study is carried out as a case-report study (baseline, IBS n=100, healthy controls n=40) followed by a dietary intervention (IBS-D n=60). Through multivariate analyses, the investigators will identify patterns of factors contributing to patient symptomatology and pathology, followed by big data analysis leading to stratification of sub-classification of irritable bowel syndrome (IBS).

Full description

Data from deep phenotype characterization of 100 patients with IBS and 40 healthy age (between 18 and 65) and gender-matched controls will be collected between May 2019 and December 2021. Psychometric tests, questionnaires, biological samples (blood, faeces, saliva and GI biopsies from antrum, duodenum and sigmoid colon), assessment of gastric accommodation and emptying using transabdominal ultrasound, vagal activity, and functional and structural magnetic resonance imaging (MRI) of the brain, will be carried out. A subgroup of 60 patients with IBS-D will be further included in a 12-week low Fermentable Oligo-, Di-, Mono-saccharides And Polyols (FODMAP) dietary intervention-study to determine short and long-term effects of diet on symptoms, microbiota composition, molecular GI signatures, cognition and behavioural traits, and structural and functional brain signatures. Deep machine learning, prediction tools and big data analysis will be used for multivariate analysis allowing disease stratification and diagnostic biomarker detection.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subject must be between 18 and 65 years of age

  • Fulfil the ROME-IV criteria for IBS

    1. Had recurrent abdominal pain on average at least 1 day per week during the previous 3 months that is associated with alterations in bowel habits.
    2. Duration at least six months.

Exclusion criteria

  • Pharmacological treatment affecting the GI-tract, including treatment for depression

  • Organic disease:

    1. coeliac disease
    2. inflammatory bowel disease
    3. neurological diseases
    4. diabetes
    5. active helicobacter pylori infection
    6. polycystic ovary syndrome
  • Treated with systemic antibiotics within the last 3 months

  • Use painkillers regularly, other than paracetamol

  • Pregnant

  • Previous intestinal surgery (appendectomy is OK)

  • Claustrophobic or have metallic implants that are not MR compatible

  • Vegan or vegetarian

  • Been travelling outside Europe within the last three weeks (or plan to travel in the nearest future)

  • Probiotics or lowFODMAP-diet within the last three weeks

  • Participation in any other simultaneous clinical study

  • Inability to comprehend and respond to questionnaires or follow dietary guidance

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

200 participants in 1 patient group

12 week lowFODMAP dietary intervention
Experimental group
Description:
Patients with IBS-D are enrolled in a 12 week strict lowFODMAP dietary intervention study.
Treatment:
Other: Dietary lowFODMAP intervention

Trial contacts and locations

1

Loading...

Central trial contact

Birgitte Berentsen, PhD; Gülen A Lied, MD., PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems